Duloxetine

Generic Name
Duloxetine
Brand Names
Cymbalta, Drizalma, Irenka, Yentreve, Duloxetine Zentiva, Duloxetine Mylan, Duloxetine Lilly
Drug Type
Small Molecule
Chemical Formula
C18H19NOS
CAS Number
116539-59-4
Unique Ingredient Identifier
O5TNM5N07U
Background

Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor. It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder. It has since received approval for a variety of indications including the tre...

Indication

Indicated for:

1) Management of Major Depressive Disorder.

2) Management of Generalized Anxiety Disorder.

3) Management of diabetic peripheral neuropathy.

4) Management of fibromyalgia.

5) Management of chronic musculoskeletal pain.

6) Management of osteoarthritis of the knee in adults.

7) Management of chronic lower back pain in adults.
...

Associated Conditions
Chronic Lower Back Pain (CLBP), Chronic Musculoskeletal Pain, Diabetic Peripheral Neuropathic Pain (DPN), Fibromyalgia, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Osteoarthritis of the Knee, Stress Urinary Incontinence (SUI)
Associated Therapies
-

Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic Pain

Phase 4
Completed
Conditions
Interventions
First Posted Date
2016-07-27
Last Posted Date
2019-07-15
Lead Sponsor
University Hospital, Strasbourg, France
Target Recruit Count
8
Registration Number
NCT02846701

Methylphenidate-Duloxetine Combinations for Cocaine Dependence

First Posted Date
2016-03-07
Last Posted Date
2018-06-26
Lead Sponsor
University of Kentucky
Target Recruit Count
13
Registration Number
NCT02700711
Locations
🇺🇸

University of Kentucky Medical Center, Lexington, Kentucky, United States

Shifting Pain Modulation From Pro-to Anti-nociceptive

First Posted Date
2016-02-03
Last Posted Date
2017-09-28
Lead Sponsor
Rambam Health Care Campus
Target Recruit Count
9
Registration Number
NCT02672202

Effects of Duloxetine on Pain Relief After Total Knee Arthroplasty in Central Sensitization Patient

First Posted Date
2015-11-09
Last Posted Date
2015-11-09
Lead Sponsor
The Catholic University of Korea
Target Recruit Count
100
Registration Number
NCT02600247

The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment

First Posted Date
2015-10-29
Last Posted Date
2018-10-11
Lead Sponsor
University of North Texas Health Science Center
Target Recruit Count
19
Registration Number
NCT02590874
Locations
🇺🇸

University of North Texas Health Science Center, Fort Worth, Texas, United States

Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery

First Posted Date
2015-08-28
Last Posted Date
2020-10-09
Lead Sponsor
Serviço de Anestesiologia de Joinville
Target Recruit Count
60
Registration Number
NCT02535000

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2015-05-13
Last Posted Date
2015-12-03
Lead Sponsor
michal roll
Target Recruit Count
50
Registration Number
NCT02443194

A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)

First Posted Date
2015-04-16
Last Posted Date
2019-09-18
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
304
Registration Number
NCT02417935

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Interventions
Drug: Phenobarbital
Drug: Phenytoin
Drug: Carbamazepine
Drug: Oxcarbazepine
Drug: Valproic Acid
Drug: Lamotrigine
Drug: Topiramate
Drug: Gabapentin
Drug: Levetiracetam
Drug: Pregabalin
Drug: Lacosamide
Drug: Clonazepam
Drug: Biperiden
Drug: Levomepromazine
Drug: Fluphenazine
Drug: Perphenazine
Drug: Perazine
Drug: Thioridazine
Drug: Haloperidol
Drug: Melperone
Drug: Pipamperone
Drug: Bromperidol
Drug: Benperidol
Drug: Sertindole
Drug: Ziprasidone
Drug: Flupentixol
Drug: Chlorprothixene
Drug: Zuclopenthixol
Drug: Fluspirilene
Drug: Pimozide
Drug: Clozapine
Drug: Olanzapine
Drug: Quetiapine
Drug: Sulpiride
Drug: Tiapride
Drug: Amisulpride
Drug: Prothipendyl
Drug: Risperidone
Drug: Aripiprazole
Drug: Paliperidone
Drug: Diazepam
Drug: Oxazepam
Drug: Lorazepam
Drug: Bromazepam
Drug: Clobazam
Drug: Alprazolam
Drug: Hydroxyzine
Drug: Buspirone
Drug: Chloral Hydrate
Drug: Flurazepam
Drug: Nitrazepam
Drug: Triazolam
Drug: Lormetazepam
Drug: Temazepam
Drug: Midazolam
Drug: Brotizolam
Drug: Zopiclone
Drug: Zolpidem
Drug: Zaleplon
Drug: Melatonin
Drug: Clomethiazole
Drug: Diphenhydramine
Drug: Promethazine
Drug: Imipramine
Drug: Clomipramine
Drug: Opipramol
Drug: Trimipramine
Drug: Amitriptyline
Drug: Nortriptyline
Drug: Doxepin
Drug: Maprotiline
Drug: Amitriptyline oxide
Drug: Fluoxetine
Drug: Citalopram
Drug: Paroxetine
Drug: Sertraline
Drug: Fluvoxamine
Drug: Escitalopram
Drug: Tranylcypromine
Drug: Moclobemide
Drug: Mianserin
Drug: Trazodone
Drug: Mirtazapine
Drug: Bupropion
Drug: Venlafaxine
Drug: Reboxetine
Drug: Duloxetine
Drug: Agomelatine
Drug: Pyritinol
Drug: Piracetam
Drug: Donepezil
Drug: Rivastigmine
Drug: Galantamine
Drug: Memantine
Drug: Nicergoline
Drug: Acamprosate
Drug: Lithium
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations
© Copyright 2024. All Rights Reserved by MedPath